EURORealTime MTB test provides direct detection of TB pathogens
Tuberculosis is one of the most prevalent infectious diseases worldwide, with 10 million new cases and an estimated 1.8 million fatalities per year according to the WHO. It is caused by pathogens of the Mycobacterium tuberculosis complex (MTBC). EUROIMMUN’s EURORealTime MTB test provides reliable direct detection of all bacteria of the MTBC in sputum, bronchoalveolar fluid and bronchial secretion by means of real-time polymerase chain reaction (real-time PCR).
The detection is based on three MTBC-specific target regions, encompassing a large number of genetic variants. The target sequences are amplified in a single multiplex PCR using highly specific primers and detected by real-time analytics. Numerous integrated controls ensure high result integrity.
The evaluation and interpretation of results is fully automated using the EURORealTime Analysis software and is thus highly standardised. The software also guides the user through the individual work steps, ensuring a simple and error-free test procedure. The entire process from sample to report release is IVD validated and CE registered.
The direct detection of tuberculosis pathogens complements other diagnostic methods such as microscopy and detection by culturing, which takes as long as 6 to 8 weeks. The PCRbased analysis thus supports early treatment and prevention of transmission.
For more information, visit: www.euroimmun.com
Supplier: EUROIMMUN AG
Website: https://www.euroimmun.com
